Identification

Symbol

AMT

ISIN code

NL0000886968

Handelssted

Amsterdam

ICB

Pharmaceuticals&Biotechnology

Activity description

Amsterdam Molecular Therapeutics (AMT) Holding B.V. is a biopharmaceutical company that develops gene-based therapies for orphan diseases.

Website address

http://www.amtbv.com

Issuer website

http://www.amtbv.com

Operation

IPO date

ons 20/06/2007

IPO type

Initial Public Offering

IPO type

Initial Public offering

Catégorie

IPO

Operation description

Offering of up to 5,000,000 new ordinary shares.

Operation calendar

Trading on Eurolist by Euronext is expected to commence on or about 20 June 2007. Settlement date is the third business day following the listing date, expected to be on or about 25 June 2007

Price range

Between €8.00 and €10.00 per offer share.